ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 53327 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 53327; 2) Community: the network communities that were significantly associated with the response to NSC 53327; 3) Molecule: the relationships between components within communities and NSC 53327; 4) MDR: the compounds that were significantly associated with the NSC 53327.

NSC Compound Enrichment Correlation
NSC 710904 Null 0.0376362543535811 -0.046581169
NSC 723906 1,4-di-N-oxide-6,7-difluor-2-phenylcarbonyl-3-trifluormethyl quinoxaline 0.0376362543535811 0.1650444
NSC 174121 Methotrexate Derivative 0.0376362543535815 0.16190434
NSC 194350 Acridine Orange 0.0376362543535815 0.36395242
NSC 268925 Di-n-octyl-secalonsaure A 0.0376362543535815 0.22407161
NSC 296301 Null 0.0376362543535815 0.28916282
NSC 402717 Null 0.0376362543535815 0.08136156
NSC 154572 Null 0.0382675857669585 -0.090072781
NSC 212509 Ergosta-2,24-dien-26-oic acid, 5,6-epoxy-4,14,17,20,22-pentahydroxy-1-oxo-, .delta.-lactone, (4.beta.,5.beta.,6.beta.,17.alpha.,22R)- (9CI) 0.0382675857669585 0.079320691
NSC 302325 2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- 0.0382675857669585 0.42923343
Total:72  Current:56    [First] [Prev] [Next] [Last]